Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

HAE

- PMLiVE

Health coverage across state lines

Despite a total lack of legislative wins, the new administration has made its presence felt at home and abroad

- PMLiVE

Shire suffers pipeline failure as takeover speculation builds

Several big pharma companies are reportedly considering bids

Andy Busch joins Shire as its CSO and head of research and development

And Howard Mayer is promoted to chief medical officer

Bayer symbol

Joerg Moeller to head Bayer R&D after operational shake-up

Andreas Busch to move to Shire as head of R&D and CSO

- PMLiVE

Thomas Dittrich takes up CFO role at Shire

He also joins the Irish biotech’s board

- PMLiVE

Shire wins CHMP backing for Adynovi

Haemophilia A treatment backed for European approval

- PMLiVE

Novartis files CAR-T therapy CTL109 in Europe

Analysts predict Kymriah could become a $1bn-plus product in Europe

EU flag

EU’s 10-year paediatric meds report – not bad, but can do better

Paper highlights the lack of ‘major therapeutic advances’ in children’s medicine

- PMLiVE

Shire’s gene therapy candidate receives orphan drug status in the US

Investigational factor VIII treatment SHP654 is being developed for haemophilia

- PMLiVE

AAA’s orphan drug Lutathera wins EU green light

The first-in-class drug treats adults with GEP-NET

- PMLiVE

EMA sets aside £32m for temporary staff to help with Brexit move

As agency warns current tender system needs to be updated

- PMLiVE

EMA faces ‘permanent damage’ if forced to go to an unpopular city

Warns eight candidate cities wouldn't retain minimum staff numbers it needs

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links